Home›Stock Screener›Sakar Healthcare›Quarterly Results

Sakar Healthcare Quarterly Results

Latest Quarter Net Profit
₹11 Cr
QMar 2026
Quarterly Results

Sakar Healthcare quarterly results. In Mar 2026, Sakar Healthcare (SAKAR) reported revenue ₹71 Cr and net profit ₹11 Cr — revenue +42.0% YoY. Check SAKAR market capitalization to track the company's total market size over time.

SAKAR Quarterly Results — Revenue, Profit & EPS Highlights

Sakar Healthcare latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Sakar Healthcare share price screener.

  • Revenue of ₹71 Cr in Mar 2026 (-5.3% vs Jun 2026, +42.0% vs Mar 2025)
  • Net Profit of ₹11 Cr in Mar 2026 (+10.0% vs Jun 2026, +83.3% vs Mar 2025)
  • EBITDA of ₹26 Cr in Mar 2026 (+13.0% vs Jun 2026)
  • Operating Margin of 37.0% in Mar 2026 (+8.0pp vs Jun 2026)
  • Earnings Per Share of ₹4.96 in Mar 2026 (+7.4% vs Jun 2026)

Sakar Healthcare Quarterly Results — Revenue, EBITDA, Net Profit & EPS

SAKAR quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 71 75 59 50 53 -5.3% 42.0%
Net Profit (₹ Cr) 11 10 5 6 5 - -
EBITDA (₹ Cr) 26 23 13 16 13 - -
EPS (₹) 4.96 4.62 2.03 2.66 2.11 - -
Operating Margin (%) 37.0% 29.0% 20.0% 31.0% 24.0% - -

SAKAR Share Price Trend — 1-Year Movement Across Quarterly Results

Sakar Healthcare 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Review Sakar Healthcare price earnings to evaluate earnings-based valuation against sector peers.

Profitability Ratios

Profit Margin 15.5%
EBITDA Margin 36.6%
Operating Margin 37.0%
ROE (Annual) 13.5%

Balance Sheet Highlights

Total Assets ₹481 Cr
Total Equity ₹325 Cr
Current Assets ₹141 Cr
Current Liabilities ₹47 Cr

Cash Flow Analysis

Operating Cash Flow ₹49 Cr
Investing Cash Flow ₹-28 Cr
Financing Cash Flow ₹-21 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹1006.80
Exchange NSE
Last Updated Oct 05, 2026

Revenue Trend (₹ Cr)

Mar 2025 50
Sept 2025 59
Jun 2026 75
Mar 2026 71

Net Profit Trend (₹ Cr)

Mar 2025 6
Sept 2025 5
Jun 2026 10
Mar 2026 11

Operating Margin Trend (%)

Mar 2025 31.0%
Sept 2025 20.0%
Jun 2026 29.0%
Mar 2026 37.0%

SAKAR vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Sakar Healthcare latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1779.7 15,018 2,710 -5.6% - 18.0% 157.5
Divis Laboratories
Mar 2026 		₹244,124.91 Cr 9196.0 2,986 751 -5.0% - 25.2% 324.8
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1139.0 7,569 1,341 -4.3% - 17.7% 90.0
Cipla
Mar 2026 		₹108,576.18 Cr 1335.5 6,612 543 -9.3% - 8.2% 194.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores